Neochromosome, Inc.
Callie Shubin, PhD, is currently a Product Manager at Neochromosome, Inc., where expertise spans across Sales, Scientists, Production, Fulfillment, and Finance, with a focus on operational efficiency. Prior roles include Scientist II, where project management and team leadership in DNA synthesis and scale-up were key responsibilities, and Scientist I, where high-throughput methods for constructing large DNA sequences were optimized. Shubin's academic background includes a PhD in Biochemistry, Cellular, and Molecular Biology from The Johns Hopkins University, along with significant research experience at esteemed institutions such as AstraZeneca and Fox Chase Cancer Center. Recognized for contributions to the field, Shubin has authored first-author publications and received awards, including the NSF GRFP fellowship.
This person is not in any teams
Neochromosome, Inc.
At Neochromosome, we enable biological engineering at a genome-scale. Our partners use our groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct pioneering scientific research. Neochromosome is uniquely suited to accelerate this work. Our first-in-class capabilities were developed to design, build, and test the world's first fully synthetic eukaryotic cells. Today, we offer our services and platform -- from highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes – to researchers around the world.